Greg is a life sciences veteran with a passion for transforming commercialization strategies. With decades of experience in pricing, market access, and patient support services, he’s a trusted advisor to both start-ups and top pharmaceutical companies. Known for his expertise in rare diseases, orphan drugs, and vaccines, Greg partners with executives to turn big ideas into commercial success, driving innovation every step of the way.